| [1] |
Araujo J,Logothetis C.Targeting Src signaling in metastatic bone disease.Int J Cancer,2009,124(1):1-6.
|
| [2] |
Wojtacki J,Kruszewski WJ,Sliwińska M,et al.Elevation of serum Ca 15-3 antigen:an early indicator of distant metastasis from breast cancer.Retrospective analysis of 733 cases.Przegl Lek,2001,58(6):498-503.
|
| [3] |
陆云飞,向俾庭,曾健,等.血清TSGF、CA153、CA125及CEA联合检测对乳腺癌的诊断价值.广西医科大学学报,2006,23(2):173-175.
|
| [4] |
Tubiana-Hulin M.Incidence,prevalence and distribution of bone metastasis.Bone,1991,12(suppl 1):S9-S10.
|
| [5] |
Harris L,Fritsche H,Mennel R,et al.American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer.J Clin Oncol,2007,25(33):5287-5312.
|
| [6] |
Nicolini A,Carpi A,Ferrari P,et al.Utility of a serum tumourmarker pane] in the post-operative follow-up of breast cancerpatients with equivocal conventional radiological examinations.Tumour Biol,2003,24(6):275-280.
|
| [7] |
Zissimopoulos A,Petrakis G,Stellos K,et al.Procollagen-I,collagen telopeptide I,CEA,CA15-3 as compared to bone scintigraphy in patients with breast cancer-Hell J Nucl Med,2006,9(1):60-64.
|